Early use patterns and long-term continuation of semaglutide for obesity in a large population

Semaglutide persistence in obesity management is assessed for factors linked to discontinuation.

• Factors associated with discontinuation of semaglutide may include patient characteristics and treatment experiences.
• Early adoption of tirzepatide for obesity management is examined as a potential alternative.
• The study highlights the importance of understanding medication persistence in managing obesity effectively.

Simplified